
In pooled CORALreef data, patients with eGFR below 60 had a 65.9% placebo-adjusted LDL-C reduction at week 24, with safety comparable to placebo.
William Dager, PharmD, BCPS, FASHP, FCCP, FCCM, MCCM, discusses the use of direct oral anticoagulants.
William Dager, PharmD, BCPS, FASHP, FCCP, FCCM, MCCM, discusses the use of direct oral anticoagulants.






